About us

Clinical Genomics Uppsala offers services with a range of molecular methods to researchers with translational or clinical projects. We also develop and implement new diagnostic tests in clinical routine.

Clinical Genomics Uppsala was jointly set up at Uppsala University and Uppsala University Hospital in 2014, to catalyze the transition of novel research findings into molecular diagnostics for clinical use. Our laboratories are integrated within the sections for Clinical Genetics, Clinical Pathology and Clinical Microbiology at the Academic Laboratory at Uppsala University Hospital. We have introduced a range of genetic tests for cancer and inherited diseases that are used on a daily basis to guide treatment decisions.

The facility is part of the national Clinical Genomics platform within the infrastructure SciLifeLab (Science for Life Laboratory). We take on research and development projects with a clear translational profile. We offer users services with a range of molecular methods, such as next generation sequencing (NGS), NanoString, digital PCR technologies and single-cell analyses. With our team of bioinformaticians, geneticists and medical doctors, we can deliver clinical assessments of the detected variants with the aim to truly provide bench-to-bedside service.

Clinical Genomics Uppsala is one of the key players in Genomic Medicine Sweden (GMS), which aims to strengthen precision medicine throughout Sweden. GMS is a collaboration between Sweden’s seven universities with a medical faculty and seven regions with university hospitals.

Group photo Clinical Genomics Uppsala

Clinical Genomics Uppsala's team includes biomedical analysts, molecular biologists, bioinformaticians, molecular biologists, clinical molecular geneticists and physicians.